News

Understanding Recent Options Trends at Synopsys Inc.

Understanding Recent Options Trends at Synopsys Inc.

Recent Trends in Options Trading for Synopsys

Investors are expressing caution as they navigate options trading related to Synopsys. Recent data indicates a marked bearish outlook among significant market players.

Reviewing the recent options activity for Synopsys (SNPS), 23 distinct trades have emerged, reflecting varied investor sentiments. Of these trades, about 26% have been bullish, while a substantial 52% have shown bearish tendencies.

Insights on Trading Patterns

Among the trades detected, 5 were puts totaling $327,592 in value, alongside 18 calls which accumulated to $1,583,821. This divergence points towards a complex perspective among traders regarding the stock's future performance.

Predicted Price Band for Synopsys

The analysis of trading volumes and Open Interest reveals that market movers are primarily concentrating on a predicted price range for Synopsys between $420.0 and $530.0. This range has been observed consistently over the past three months and highlights the current market dynamics.

Current Volume and Open Interest Data

For today, the average open interest in Synopsys options trades stands at 249.0, while the total volume reached an impressive 2,219.00. The volume and open interest for Synopsys options provide a glimpse into the prevailing market sentiment and liquidity.

Analysis of Key Options Activity

To grasp how Synopsys is performing within the options market, let’s examine some of the notable trades within the past 30 days:

Highlighted Options Activity

The most significant trades reflect a mix of investor sentiments:

  • SNPS CALL: Neutral sentiment with a trade price around $58.0 and an outstanding total trade price of $290.0K.
  • SNPS PUT: Also neutral, trading at a price of $42.5 with a total trade valuation of $212.5K.
  • SNPS CALL: Bearish trends observed, trading for $8.8 against a strike price of $510.00, culminating in a trade value of $184.8K.
  • SNPS CALL: Another bearish sentiment, priced at $36.3 with a significant total trade price involving $163.3K.
  • SNPS CALL: Notably bearish as well, with trading signals reflecting a $23.1 price point and a total valuation hitting around $138.6K.

Overview of Synopsys

With a strong foundation in electronic design automation (EDA) software, Synopsys continues to be a pivotal player in the semiconductor and design industry. Their tools foster enhanced productivity and accuracy in chip design processes, benefiting from the growing trend where semiconductor firms are increasingly converging towards comprehensive system solutions.

The digital transformation trend across various market sectors is favorable for EDA companies like Synopsys, thereby expanding their customer base and potential for growth.

Current Standing of Synopsys

  • Currently, Synopsys’s stock shows promising growth, registering a price increase of 2.49% at $469.34.
  • Trading volume has been reported at 815,436, suggesting considerable market activity.
  • Technical indicators such as RSI point towards the stock potentially becoming oversold soon.
  • Anticipated earnings results are just on the horizon, marking another important date for investors.

Expert Commentary on Synopsys

Investment professionals have taken interest in Synopsys with two recent ratings suggesting a bullish outlook, converging around a consensus target price near $625.0.

Market analysts have commented on unusual options activity lately, indicating that significant market participants are positioning themselves strategically amidst current trends. An analyst from Morgan Stanley holds an Overweight rating for Synopsys with projections at $590, while their Rosenblatt counterpart has issued a Buy recommendation coupled with a heightened target of $660.

Navigating options trading presents inherent risks but also significant opportunities for those who are educated and flexible in their strategies. Keeping track of evolving market signals continues to be vital for traders involved in Synopsys.

Frequently Asked Questions

What is the current sentiment on Synopsys options trading?

The recent sentiment shows a significant bearish trend among major investors, with 52% of trades reflecting this outlook.

What is the predicted price range for Synopsys?

The predicted price range for Synopsys is between $420.0 and $530.0, based on recent trading volumes and Open Interest analyses.

What are the recent trading volumes for Synopsys options?

The mean open interest for Synopsys options is 249.0, with a total trading volume recorded at 2,219.00 today.

What do experts say about Synopsys's future performance?

Market analysts maintain a positive outlook on Synopsys, with a consensus target price around $625.0 and comments about potential future growth based on market conditions.

How should traders approach options trading in Synopsys?

Traders should focus on education, adapting to market changes, and utilizing various indicators to manage risks effectively while engaging in options trading.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

First Horizon's $25M Bet: New Center Transforms Houston

Updated Category News Views 187

New Markets Tax Credits: A Game Changer First things first, if you're thinking this is some typical charitable write-off, think again. First Horizon Bank (NYSE: FHN) is deep in the mix of something pretty transformative in the world of finance and community support. They're not just throwing money at a problem and hoping it sticks. Nope, we're talking real strategy with a...

Continue Reading
Chime Joins S&P MidCap 400 Amid Merger Jostle

Updated Category News Views 194

Index Shake-Up: Who's In, Who's Out? Hold onto your hats, folks—big changes are coming to the S&P MidCap 400! Chime Financial Inc. is crashing the party, taking a seat at the table, as NorthWestern Energy Group gets the boot. Now, if that doesn’t grab your attention, I don’t know what will. You've got to appreciate the chaos and opportunities that come with a roster...

Continue Reading
Choosing Expert European Auto Repair: Key Insights

Updated Category News Views 142

The Perks of Specialist Knowledge Ever get the feeling your local auto shop doesn't always cut it when your sleek BMW or classy Mercedes needs a tweak? You're not alone. Specifically, for those driving around Alpharetta, European vehicles demand not just routine check-ups but specialist hands. Much like how you wouldn't hand your luxury timepiece to the shop down the...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 197

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Schools Reimagine Yearbooks with Interactive Archives

Updated Category News Views 133

Revamping School Memories for the Tech Age In a world where every facet of life is digitally chronicled, it's about time schools got on board the archival train in a dynamic way. That's where Rocket Alumni Solutions steps in, breathing fresh life into those dust-gathering yearbooks and sepia-toned photos. Tackling History Collection by Collection Think you can throw a...

Continue Reading
CR&R Workers Join Teamsters, Fight for Fair Conditions

Updated Category News Views 91

Waste Workers Push Back Against Corporate Pressure The Southern California sun isn't the only thing heating up these days; the waste workers at CR&R Environmental Services have cranked up the heat by voting to join Teamsters Local 396. It's like Groundhog Day in the world of labor rights—same story, different locale, workers banding together for a fair shot. A Stand...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 111

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
BIBIBOP Brings Good Vibes with OLIPOP Happy Hour

Updated Category News Views 175

Boosting Midday Energy with BIBIBOP's New Promo Here we go, folks. BIBIBOP Asian Grill is dialing up the culinary energy just when you need it most. From November 16 to 22, during their Good Energy Happy Hour, they’re serving up a deal designed to pump some pep into your afternoon—free OLIPOP prebiotic soda with any regular bowl purchase. Just stroll into any of their...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 201

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 124

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading

Top 5 Most Recently Viewed Articles

Inspiring Journey of Students Overcoming Homelessness

Updated Category News Views 251

Inspiring Story of Resilience Among Students Recently, 72 remarkable students facing homelessness were celebrated for completing the New Horizons Academy at Governor Thomas Johnson High School. This transformative program was organized by the Student Homelessness Initiative Partnership (SHIP) in collaboration with local public schools. It’s a testament to the strength...

Continue Reading
BitFuFu Reports Stellar June Bitcoin Production and Growth

Updated Category News Views 171

BitFuFu's Production Milestones in June 2025 In June 2025, BitFuFu Inc. (NASDAQ: FUFU) demonstrated impressive growth as a leader in Bitcoin mining, achieving significant milestones in production. The company's recent operational updates revealed that BitFuFu increased its Bitcoin production by 11.3% month-over-month, totaling 445 BTC. As a result, its overall Bitcoin...

Continue Reading
MAP Medical Enhances Healthcare Supply Solutions with New Partner

Updated Category News Views 111

MAP Medical Partners with Metrix-Secure for Enhanced Supply Solutions MAP Medical has officially announced a strategic partnership with Metrix-Secure, a manufacturer widely recognized for its excellence in IV delivery systems. This collaboration positions MAP Medical as an authorized distributor for Metrix-Secure, significantly bolstering its offerings to healthcare...

Continue Reading
Conversations for End-of-Life Care: A Guide to Planning Wisely

Updated Category News Views 179

Open Conversations About End-of-Life Care As we approach significant observances aimed at improving healthcare decisions, many experts emphasize the importance of discussing advance care planning and end-of-life wishes. Surprisingly, studies reveal that only 50% of Americans have engaged in these crucial conversations, leaving a significant number without clear directives...

Continue Reading
Kent Outdoors Welcomes Nate Romney as New CFO

Updated Category News Views 264

Kent Outdoors Welcomes Nate Romney as New CFO Kent Outdoors, renowned for its commitment to outdoor adventures for over 60 years, has recently appointed Nate Romney as its Chief Financial Officer (CFO). This move marks a significant step for the company as it looks to leverage Romney's extensive experience in finance and operations to enhance its growth trajectory....

Continue Reading